汤剂
药理学
中医药
药效学
治疗效果
MAPK/ERK通路
传统医学
医学
信号转导
生物
药代动力学
生物化学
病理
替代医学
作者
Jie Kang,Yang Xu,Nan Sui
标识
DOI:10.2174/0113862073332162241126105559
摘要
This study confirmed that ZSD could act on AKT1, MAPK12, and MAPK14 targets to activate the p38/MAPK signaling pathway to relieve FC induced by defenoxate tablets. The further development of ZSD provided a theoretical basis.
科研通智能强力驱动
Strongly Powered by AbleSci AI